FDA-filed SPL labeling · retrieved through openFDA

Moxifloxacin

Moxifloxacin is a fluoroquinolone antibiotic available as oral tablets, intravenous infusion, and eye drops, used to treat a range of bacterial infections in adults — from pneumonia and skin infections to bacterial pink eye.

Brand names AveloxVigamoxMoxeza
Drug class Fluoroquinolone Antibacterial
Rx Forms 3 Routes Ophthalmic · Oral · Intravenous
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 10, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 25 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

At a glance
Linked label effectiveOct 9, 2025
Clinical labels in scope 25
AvailabilityRx
Earliest approval/marketing year 1999
FDA-listed product records 143
Boxed warningYes
How we combine label and product data →
Other forms & routes:
Moxifloxacin at a glance The quick version — the full detail is in the Patient Information Guide below.
💊
HelloPharmacist Editorial Team Bottom Line
Moxifloxacin is a powerful antibiotic that works well for serious bacterial infections, but it comes with real risks that set it apart from most other antibiotics — including potential for permanent nerve or tendon damage and heart rhythm effects. Take it exactly as prescribed, finish the full course, and don't ignore new pain, tingling, mood changes, or irregular heartbeat. If something feels off after starting it, reach out to your pharmacist or doctor promptly.
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert

Moxifloxacin carries the FDA's most serious warning because it can cause disabling and potentially permanent side effects. These include tendinitis and tendon rupture (especially in the Achilles tendon at the back of the ankle), nerve damage in the arms and legs (peripheral neuropathy), and serious mental or nervous system effects like hallucinations, depression, anxiety, and seizures. These reactions can happen together, can start within hours of your first dose, and may not be fully reversible. Stop taking moxifloxacin and call your doctor right away if you notice any of these. Moxifloxacin can also worsen muscle weakness in people with myasthenia gravis — in some cases severely enough to require a breathing machine — so it should be avoided in those patients. Because of these risks, moxifloxacin should only be used for sinus infections and chronic bronchitis flare-ups when there is truly no safer alternative antibiotic available.

Read the full warning on DailyMed →

📖 Moxifloxacin: Patient Information Guide

A plain-language walkthrough of Moxifloxacin — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.

🎯What it's used for

Moxifloxacin is a fluoroquinolone antibiotic approved to treat several types of bacterial infections in adults, available in different forms for different uses:

  • Oral tablets and IV injection: Community-acquired pneumonia
  • Oral tablets and IV injection: Uncomplicated skin and skin structure infections
  • Oral tablets and IV injection: Complicated skin and skin structure infections
  • Oral tablets and IV injection: Complicated intra-abdominal infections (infections inside the belly)
  • Oral tablets and IV injection: Plague
  • Oral tablets and IV injection (use only when no alternative exists): Acute bacterial sinusitis
  • Oral tablets and IV injection (use only when no alternative exists): Acute bacterial exacerbation of chronic bronchitis (sudden worsening of a chronic lung condition)
  • Moxifloxacin ophthalmic solution (eye drops), including Vigamox: Bacterial conjunctivitis (pink eye) — for topical eye use only, not for body-wide infections
⚙️How it works

Moxifloxacin is a bactericidal antibiotic — meaning it actually kills bacteria rather than just stopping them from growing. It does this by blocking two enzymes bacteria rely on to copy and repair their DNA: DNA gyrase (topoisomerase II) and topoisomerase IV. Without these enzymes, the bacteria's genetic material becomes damaged and disorganized, and the bacteria die off.

Because it works through this unique mechanism, moxifloxacin is active against a wide range of bacteria, including some that are resistant to other types of antibiotics. Like all antibiotics, it should only be used for infections caused by bacteria it can actually target — not for viral infections like the flu or a cold.

💊How it's taken

Oral moxifloxacin tablets are taken once daily and can be taken with or without food — even a high-fat meal or yogurt does not reduce how well it's absorbed. If you take antacids, sucralfate, iron supplements, zinc, or multivitamins, take moxifloxacin at least 4 hours before or 8 hours after those products, as they can significantly reduce how much antibiotic gets into your system. The IV injection form is given once daily as a slow infusion over 60 minutes in a clinical setting and should never be given as a rapid injection; it should also not be mixed with other medications in the same IV bag or line. Moxifloxacin ophthalmic solution (eye drops) is used topically in the affected eye — one drop several times daily for 7 days depending on the specific product labeling. Always follow your prescriber's exact instructions and complete the full prescribed course even if you feel better earlier.

  • Oral tablets: Once daily, with or without food; space away from antacids and mineral supplements
  • IV infusion: Once daily over 60 minutes, given in a healthcare setting
  • Eye drops: Instilled in the affected eye as directed (typically 2–3 times daily for 7 days depending on formulation)
🤒Side effects — in detail

The most common side effects with oral or IV moxifloxacin include:

  • Nausea
  • Diarrhea
  • Headache
  • Dizziness
  • Vomiting
  • Trouble sleeping (insomnia)
  • Constipation
  • Abdominal pain

More serious reactions — including tendon damage, nerve problems, severe allergic reactions, dangerous heart rhythm changes, and C. diff–related bowel infection — require stopping the medication and getting medical help right away. These are not common, but they are real risks with this class of antibiotic.

⚠️Warnings & precautions
  • Tendon damage: Moxifloxacin can cause tendinitis (tendon inflammation) or tendon rupture — most often the Achilles tendon. Risk is highest in people over 60, those taking corticosteroids, and organ transplant recipients. Stop and seek care at the first sign of tendon pain or swelling.
  • Nerve damage (peripheral neuropathy): Numbness, tingling, burning, or weakness in the arms or legs can develop quickly and may be irreversible. Stop the drug and call your doctor immediately if these occur.
  • Central nervous system effects: Hallucinations, paranoia, depression, suicidal thoughts, confusion, seizures, and dizziness have been reported — sometimes after just the first dose.
  • QT prolongation: Moxifloxacin can alter heart rhythm in a way that may trigger a dangerous arrhythmia. Avoid if you already have a prolonged QT interval, low potassium, or are on certain heart or psychiatric medications.
  • Myasthenia gravis: Can severely worsen muscle weakness in people with this condition — avoid use entirely if you have myasthenia gravis.
  • Severe allergic reactions: Anaphylaxis (life-threatening allergic reaction) can occur with the very first dose. Stop and seek emergency care if you develop hives, swelling, throat tightness, or difficulty breathing.
  • C. diff–associated diarrhea: Like all antibiotics, moxifloxacin can disrupt gut bacteria and allow C. difficile to overgrow, causing severe, potentially life-threatening diarrhea. Report any significant diarrhea after starting antibiotics.
  • Blood sugar changes: Both high and dangerously low blood sugar have been reported, especially in diabetic patients on insulin or sulfonylureas. Monitor blood glucose closely.
  • Risk of aortic aneurysm: Epidemiologic data suggest a possible increased risk of aortic aneurysm (a dangerous ballooning of the aorta) within two months of use — particularly in older adults or those already at elevated risk.
🔀What it interacts with

Moxifloxacin has several meaningful interactions to be aware of:

  • Antacids, sucralfate, iron, zinc, multivitamins: These bind to moxifloxacin in the gut and can dramatically reduce how much is absorbed. Take moxifloxacin at least 4 hours before or 8 hours after these products.
  • Warfarin (blood thinner): Moxifloxacin can boost warfarin's blood-thinning effect, increasing bleeding risk. Close INR monitoring is needed.
  • Class IA antiarrhythmics (quinidine, procainamide) and Class III antiarrhythmics (amiodarone, sotalol): These already affect heart rhythm; combining them with moxifloxacin significantly raises the risk of a dangerous arrhythmia. Avoid the combination.
  • Other QT-prolonging drugs (certain antipsychotics, tricyclic antidepressants, erythromycin, cisapride): Additive risk of QT prolongation and arrhythmia — use with caution and discuss with your prescriber.
  • Diabetes medications (insulin, sulfonylureas): Blood sugar disturbances — especially dangerous lows — are more likely when combined. Monitor blood glucose carefully.
  • NSAIDs (ibuprofen, naproxen, etc.): Taking NSAIDs alongside fluoroquinolones may increase the risk of seizures.

This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.

📋Before taking it
  • Allergy to quinolones: Do not take moxifloxacin if you've had a serious allergic reaction to moxifloxacin or any other quinolone antibiotic (e.g., ciprofloxacin, levofloxacin).
  • Myasthenia gravis: Moxifloxacin is contraindicated — it can cause life-threatening muscle weakness worsening in people with this condition.
  • History of tendon problems: Prior tendinitis or tendon rupture raises the risk further — discuss alternatives with your doctor.
  • Heart conditions or QT-prolonging medications: Tell your doctor about any heart rhythm problems, low potassium, or medications that affect the QT interval before starting moxifloxacin.
  • Older adults (60+): Higher risk of tendon damage and QT-related heart rhythm changes. Those taking corticosteroids are at especially elevated risk for tendon rupture.
  • Pregnancy: Animal studies show potential fetal harm. There are no adequate human data. Discuss the risks and benefits with your provider.
  • Breastfeeding: Moxifloxacin may pass into breast milk based on animal data. Weigh the benefits of breastfeeding against potential risk to the infant.
  • Children under 18: Safety and effectiveness have not been established for systemic (oral or IV) use. Moxifloxacin also causes joint cartilage damage in young animals.
  • Diabetes: Blood sugar can swing high or low — extra monitoring is needed if you're on insulin or oral diabetes drugs.
  • Liver cirrhosis: Use with caution in patients with mild, moderate, or severe liver cirrhosis.
  • High sodium diet or heart failure: The IV formulation contains a significant amount of sodium — those on sodium-restricted diets or with congestive heart failure should discuss this with their doctor.
🚑If you take too much

Single oral overdoses up to a large amount have been reported without serious events in some cases, but any suspected overdose should be treated with care. If an overdose happens, emptying the stomach, maintaining good hydration, and monitoring heart rhythm (EKG) are recommended steps. Activated charcoal given soon after an oral overdose may help reduce how much moxifloxacin the body absorbs.

📡Pharmacodynamics — effects in the body

Moxifloxacin kills bacteria by disrupting two enzymes essential to bacterial DNA function. Studies in healthy volunteers found that moxifloxacin does not appear to cause significant photosensitivity (skin sensitivity to sunlight) at standard doses — unlike some other fluoroquinolones. The drug can, however, prolong the QT interval on a heart tracing (EKG), a measurable electrical change in the heart that, in some circumstances, can increase the risk of serious arrhythmias (abnormal heart rhythms), particularly at higher concentrations or faster infusion rates.

🔬Pharmacokinetics — how your body processes it

Oral moxifloxacin tablets are very well absorbed — about 90% of the dose reaches the bloodstream, and food (even high-fat meals or yogurt) does not meaningfully change this. The drug has a half-life of roughly 12–16 hours with oral dosing, meaning it stays active in the body long enough to be effective with once-daily dosing. IV infusion delivers the drug more directly but results in similar overall drug exposure to the oral form. Moxifloxacin distributes widely throughout the body and does not require dose adjustments for kidney or liver impairment under standard prescribing guidelines.

📦How to store it

Store at 20° to 25°C (68° to 77°F) .

📄 Written from Moxifloxacin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →

155

Supplements & herbs that interact with Moxifloxacin

155 supplements and herbal products have documented interactions with Moxifloxacin in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.

Severity mix
  • Major · 13
  • Moderate · 121
  • Minor · 21
Every supplement checked against Moxifloxacin — ranked by severity The full interaction hub: 13 major · 121 moderate · 21 minor · every one linked to its full report. Check Moxifloxacin against your exact supplements

Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

11

Nutrient depletion considerations

Moxifloxacin has been associated with lower levels of 11 nutrients in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.

Evidence & significance mix
  • Higher significance · 10
  • Moderate · 1
See the full Moxifloxacin nutrient depletion report

Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.

🩺 Pharmacist Counseling Corner

Quick, plain-English answers to the questions patients ask most about Moxifloxacin — the kind of thing our pharmacy team would talk through with you at the counter.

Can I eat or drink normally while taking moxifloxacin tablets?
Yes — you can take moxifloxacin with or without food, and even a big, fatty meal or a cup of yogurt won't affect how well it works. The one thing to watch is timing with antacids, iron supplements, zinc, or multivitamins. Those can block the antibiotic from being absorbed properly, so try to take moxifloxacin at least 4 hours before or 8 hours after those products.
What side effects should I actually expect, and which ones should make me stop taking it?
The most common ones are nausea, diarrhea, headache, and dizziness — these are annoying but usually manageable. What you really need to stop the medication for and call your doctor about right away includes tendon pain or swelling (especially around your heel or shoulder), numbness or tingling in your hands or feet, new mood changes like anxiety, confusion, or depression, an irregular heartbeat, or a severe allergic reaction like facial swelling or trouble breathing. Don't push through those — reach out immediately.
I've heard fluoroquinolones can damage tendons. Is that really a concern with moxifloxacin?
Yes, it's a real risk — not common, but serious enough that the FDA put it in a boxed warning. Moxifloxacin can cause tendon inflammation or even rupture, most often in the Achilles tendon. Your risk is higher if you're over 60, taking steroid medications, or have had a kidney, heart, or lung transplant. If you feel pain, swelling, or anything unusual in a tendon during or even after your course of treatment, stop the medication and contact your doctor. Rest the area and don't push through the pain.
I take warfarin for a blood clot. Is it safe to use moxifloxacin at the same time?
You can use them together, but your doctor needs to know — moxifloxacin can increase warfarin's blood-thinning effect, which raises your bleeding risk. Your INR (a measure of how quickly your blood clots) should be monitored more closely while you're on moxifloxacin and for a bit after you finish. Watch for unusual bruising or bleeding and report it.
Is moxifloxacin safe during pregnancy or while breastfeeding?
There aren't enough human studies to say it's definitely safe, and animal studies have shown some potential risk to the developing baby. If you're pregnant or breastfeeding, this is an important conversation to have with your doctor before starting it — they'll weigh whether the benefit of treating your infection outweighs any potential risk to you and your baby.
Can my child take moxifloxacin tablets or the IV form?
No — the oral tablets and IV injection are only approved and established as safe and effective for adults 18 and older. Moxifloxacin has been shown to cause joint and cartilage damage in young animals, which is a reason for caution in growing children. If your child has an infection, their doctor will choose a different antibiotic that's appropriate for their age.
Is Moxifloxacin available over the counter?
Moxifloxacin is dispensed by prescription according to its FDA labeling, so it isn't sold over the counter. Your prescriber and pharmacist will determine if it's appropriate for you.
When was Moxifloxacin first available?
Moxifloxacin has been available in the United States since at least 1999, based on FDA approval history (Drugs@FDA) and product marketing records.
Who makes Moxifloxacin?
Moxifloxacin is supplied by 62 manufacturers listed in the FDA NDC Directory, including A-S Medication Solutions, PD-Rx Pharmaceuticals, Inc., Aurobindo Pharma Limited.

💬 Answers drafted from Moxifloxacin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →

🧰 Keep exploring

💊 How Moxifloxacin comes

Moxifloxacin is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Tablet

By mouth
Available strengths 1 strength
59 FDA-listed product records

Eye drops

In the eye
Brands Moxeza Vigamox
Available strengths 1 strength
57 FDA-listed product records

Injection

Into a vein
Available strengths 1 strength
7 FDA-listed product records

📊 Moxifloxacin across the U.S. market

How Moxifloxacin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

3
Dose forms
62
Manufacturers
6
Brand names
143
FDA-listed product records
1999
First marketed

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (20) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

A-S Medication Solutions14%
PD-Rx Pharmaceuticals, Inc.9%
Aurobindo Pharma Limited6%
Direct Rx5%
Bryant Ranch Prepack5%
Lupin Pharmaceuticals, Inc.3%
Other makers58%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

📈 How widely Moxifloxacin is used

A general measure of how commonly Moxifloxacin is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Moxifloxacin is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

251,847
Medicaid prescriptions filled (Q1–Q4 2025)
$4.5M gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Moxifloxacin prescribed? Of the 1,596 medications we measure, Moxifloxacin ranks #357 by Medicaid prescriptions — more than 78% of them.

Where Moxifloxacin ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Moxifloxacin product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

The 5 mg/mL ophthalmic solution is the most-dispensed Moxifloxacin product — about 86% of these Medicaid prescriptions.

moxifloxacin 5 MG/ML Ophthalmic Solution Most dispensed

215,639 Medicaid prescriptions (Q1–Q4 2025) 86% of Moxifloxacin prescriptions shown $3.6M gross reimbursement (before rebates) ≈ $17 per prescription (gross)

Summed across the 12 of 41 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 403818

moxifloxacin 400 MG Oral Tablet

36,008 Medicaid prescriptions (Q1–Q4 2025) 14% of Moxifloxacin prescriptions shown $863,989 gross reimbursement (before rebates) ≈ $24 per prescription (gross)

Summed across the 3 of 67 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 311787

250 ML moxifloxacin 1.6 MG/ML Injection

200 Medicaid prescriptions (Q1–Q4 2025) <1% of Moxifloxacin prescriptions shown $2,180 gross reimbursement (before rebates) ≈ $11 per prescription (gross)

Summed across the 1 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 351156

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Moxifloxacin, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 16 of 112 listed Moxifloxacin NDCs with Medicaid activity.

🔍 Compare Moxifloxacin products

A representative set of FDA-listed product records for Moxifloxacin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 143 of 143 products — FDA National Drug Code Directory. See every product, package size and price: browse all 143 Moxifloxacin NDCs →

RxNorm Concept Web — From Ingredient to Every Form and Strength

This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.

Ingredient (IN) Moxifloxacin RxCUI 139462 3 dose forms · 3 strengths
  1. Dose form (SCDF) Injection RxCUI 1665194 In current FDA listings
    Clinical drug / strength (SCD) 250 ML moxifloxacin 1.6 MG/ML RxCUI 351156
  2. Dose form (SCDF) Ophthalmic Solution RxCUI 406106 In current FDA listings
    Clinical drug / strength (SCD) 5 MG/ML RxCUI 403818
  3. Dose form (SCDF) Oral Tablet RxCUI 374619 In current FDA listings
    Clinical drug / strength (SCD) 400 MG RxCUI 311787

Look up RxCUI 139462 in the RxCUI Atlas →

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

🏷️ Sold under these brand names

Avelox Vigamox Moxeza

🏭 Manufacturers & labelers

A-S Medication Solutions 17 PD-Rx Pharmaceuticals, Inc. 11 Aurobindo Pharma Limited 7 Direct Rx 6 Bryant Ranch Prepack 6 Lupin Pharmaceuticals, Inc. 4 RPK Pharmaceuticals, Inc. 4 Remedyrepack Inc. 4 Golden State Medical Supply, Inc. 4 American Health Packaging 3 Apotex Corp. 3 Redpharm Drug 3 Fresenius Kabi USA, LLC 3 Advanced Rx Pharmacy of Tennessee, LLC 3 Mylan Pharmaceuticals Inc. 2 MSN Pharmachem Private Limited 2 Dr. Reddy's Laboratories Limited 2 Fosun Pharma USA Inc. 2 Professional Compounding Centers of America 2 Hetero Drugs Limited 2 Mylan Institutional LLC 2 Novartis Pharmaceuticals Corporation 2 NorthStar Rx LLC 2 Major Pharmaceuticals 2

…and 16 more on the FDA NDC directory.

🔬 Where this comes from

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Oct 9, 2025
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Moxifloxacin.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Moxifloxacin after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
25
NDC products indexed
143
Distinct labelers/manufacturers represented
62
Linked representative label
Camber Pharmaceuticals, Inc.
Linked label effective
Oct 9, 2025
Composite sections available
24
Linked SPL Set ID
1e6bc886-eec9-4cd8-be78-7563817457f2
Linked SPL Document ID
40b874c7-8b88-6a93-e063-6394a90ad44f
Open the linked representative label on DailyMed ↗

How we combine label and product data

HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 25 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.

For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Camber Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.

This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.